Simpex Pharma

Founded: 2010 • Age: 16 yrs
Pharmaceutical manufacturing and distribution of medicines in India.

About Simpex Pharma

Simpex Pharma is a Healthcare company founded in 2010. It operates as a pharmaceutical manufacturing and distribution of medicines in India. The company has 157 employees. Its Indian entity Simpex Pharma Private Limited reported revenue of β‚Ή70.72 Cr. Simpex Pharma offers products and services including Medicines and Research and Development Services. Its focus areas include Research and Development, Biotechnology, Drug Innovation and Pharmaceuticals.

Company details

Simpex Pharma Pvt. Ltd. is recognized as a fast-growing pharmaceutical entity that operates with a vertically and diagonally integrated model, focusing on the production of a diverse range of medicines. Its facilities are situated in eco-friendly locations in India, emphasizing waste management and quality standards. The company is noted for its research-driven approach, holding various certifications and producing products across key therapeutic areas like cardiovascular and diabetes treatments. Environmental sensitivity and global distribution are highlighted in its operations, ensuring accessibility to healthcare solutions worldwide.

  • Employees 157
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Social Instagram
  • Legal Name Simpex Pharma Pvt. Ltd
  • Date of Incorporation 07 Mar, 1997
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹70.72 Cr

    FY 2025 · +24% YoY

  • Net Profit
    ₹5.18 Cr

    FY 2025 · 7% margin

  • EBITDA
    ₹10.37 Cr

    FY 2025 · 15% margin

  • Employee Count
    157

Products & Services of Simpex Pharma

Simpex Pharma offers a comprehensive portfolio of products and services, including Medicines and Research and Development Services.

Medicines
Pharmaceutical Products

Various medicines are produced for therapeutic areas such as antibiotics and anti-allergic drugs, serving global healthcare needs

Research and Development Services
Innovation Services

Research and development services are provided for drug delivery systems and formulations, supporting ongoing pharmaceutical advancements

Board of directors of Simpex Pharma Private Limited (Simpex Pharma)

Simpex Pharma Private Limited is the primary company behind Simpex Pharma. The board of Simpex Pharma Private Limited currently have 3 directors; the longest-serving is Naresh Santhanam, appointed in 2010. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Naresh Santhanam
DIN 02920517
Director15 Feb 201016 yrs 8 moSimpex Pharma Private Limited
Ajay Kumar Mishra
DIN 02968198
Director06 Apr 201016 yrs 6 moSimpex Pharma Private Limited
Piyush Kumar Singh
DIN 00863068
Director02 Jan 20206 yrs 9 moSimpex Pharma Private Limited

Financials of Simpex Pharma

Figures of Simpex Pharma Private Limited, the primary company behind Simpex Pharma, for FY 2025. Revenue was ₹70.72 Cr (+24% year on year). Net profit was ₹5.18 Cr (7% margin). EBITDA was ₹10.37 Cr (15% margin). Revenue has grown at a compounded annual rate of +35% over three years and +27% over five years.

  • ₹70.72 CrRevenue · FY 2025 · +24% YoY
  • ₹5.18 CrNet profit · 7% margin
  • ₹10.37 CrEBITDA · 15% margin
  • ₹2.50 CrPaid-up capital
  • 157Employees (provident fund records)
  • +35%Revenue CAGR, 3 years
  • +27%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Simpex Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Simpex Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

10 companies that operate in the same segment as Simpex Pharma (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Genetic services are provided by Colossal's laboratory operations.
2021Austin, Texas, United StatesUSD 617.6 M––
Research lab engaged in pharmacological measurements on therapeutic protein variants
2018United StatesUSD 78.19 M–22
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, India–USD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, India–USD 4.22 M228
Medical research labs are provided by GALY for scientific purposes.
2018Boston, Massachusetts, United StatesUSD 61.59 M–25
Laboratory focused on biotechnology & molecule research services
2018Cambridge, Massachusetts, United StatesUSD 32.68 M––
Laboratory delivers discovery & research in nuclear and particle physics
1947United States––2,436
Research and manufacturing of hemp products are conducted by BRC.
2017Monterey, California, United StatesUSD 25.26 M–16
Genome sequencing studies are conducted for medical research purposes.
2020Cambridge, Cambridgeshire, United KingdomUSD 11.26 M–12
Novel immunotherapy therapeutic targets are discovered through laboratory research.
2019Branford, Connecticut, United StatesUSD 92 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Simpex Pharma

Simpex Pharma was founded in 2010.

Simpex Pharma has 157 employees.

The primary company behind Simpex Pharma, Simpex Pharma Private Limited, reported revenue of β‚Ή70.72 Cr for FY 2025, up 24% year on year.

Simpex Pharma Pvt. Ltd. is recognized as a fast-growing pharmaceutical entity that operates with a vertically and diagonally integrated model, focusing on the production of a diverse range of medicines. Its facilities are situated in eco-friendly locations in India, emphasizing waste management and quality standards. The company is noted for its research-driven approach, holding various certifications and producing products across key therapeutic areas like cardiovascular and diabetes treatments. Environmental sensitivity and global distribution are highlighted in its operations, ensuring accessibility to healthcare solutions worldwide.

Simpex Pharma offers Medicines and Research and Development Services.

Simpex Pharma operates through Simpex Pharma Private Limited.

The legal entities of Simpex Pharma currently have 3 directors, including Naresh Santhanam, Ajay Kumar Mishra, Piyush Kumar Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available